For instance, Hamczyk et al. demonstrated that TUDCA treatment ameliorates the vascular phenotype in progeria mouse models and extends lifespan in Apoe-/-LmnaLCS/LCS SM22α-Cre mice 54. This evidence concerns the gene APOE and progeroid syndrome.